Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultragenyx Pharmaceutical (RARE) Goodwill & Intangibles: 2017-2025

Historic Goodwill & Intangibles for Ultragenyx Pharmaceutical (RARE) over the last 8 years, with Sep 2025 value amounting to $217.3 million.

  • Ultragenyx Pharmaceutical's Goodwill & Intangibles rose 3.82% to $217.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $217.3 million, marking a year-over-year increase of 3.82%. This contributed to the annual value of $222.7 million for FY2024, which is 2.08% up from last year.
  • Latest data reveals that Ultragenyx Pharmaceutical reported Goodwill & Intangibles of $217.3 million as of Q3 2025, which was down 0.82% from $219.1 million recorded in Q2 2025.
  • In the past 5 years, Ultragenyx Pharmaceutical's Goodwill & Intangibles ranged from a high of $222.7 million in Q4 2024 and a low of $175.3 million during Q3 2021.
  • In the last 3 years, Ultragenyx Pharmaceutical's Goodwill & Intangibles had a median value of $210.6 million in 2024 and averaged $212.3 million.
  • Per our database at Business Quant, Ultragenyx Pharmaceutical's Goodwill & Intangibles increased by 18.50% in 2022 and then fell by 0.54% in 2023.
  • Over the past 5 years, Ultragenyx Pharmaceutical's Goodwill & Intangibles (Quarterly) stood at $175.7 million in 2021, then climbed by 18.50% to $208.2 million in 2022, then grew by 4.80% to $218.2 million in 2023, then rose by 2.08% to $222.7 million in 2024, then rose by 3.82% to $217.3 million in 2025.
  • Its Goodwill & Intangibles was $217.3 million in Q3 2025, compared to $219.1 million in Q2 2025 and $220.9 million in Q1 2025.